Lionel Galibert

519 total citations
15 papers, 407 citations indexed

About

Lionel Galibert is a scholar working on Molecular Biology, Genetics and Insect Science. According to data from OpenAlex, Lionel Galibert has authored 15 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Genetics and 3 papers in Insect Science. Recurrent topics in Lionel Galibert's work include Viral Infectious Diseases and Gene Expression in Insects (11 papers), Virus-based gene therapy research (10 papers) and Insect Resistance and Genetics (6 papers). Lionel Galibert is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (11 papers), Virus-based gene therapy research (10 papers) and Insect Resistance and Genetics (6 papers). Lionel Galibert collaborates with scholars based in France, Finland and United States. Lionel Galibert's co-authors include Otto‐Wilhelm Merten, Yannis Michalakis, Marilyne Uzest, Denis Roze, Stéphane Blanc, Rémy Froissart, Otto-Wilhelm Merten, Martin Marek, Just M. Vlak and Monique M. van Oers and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Lionel Galibert

15 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lionel Galibert France 11 250 176 122 99 49 15 407
Changyong Liang China 12 272 1.1× 88 0.5× 82 0.7× 95 1.0× 17 0.3× 28 360
Robert Heler United States 9 665 2.7× 148 0.8× 51 0.4× 108 1.1× 59 1.2× 9 717
Chantal K. Guegler United States 7 583 2.3× 179 1.0× 49 0.4× 87 0.9× 81 1.7× 8 674
Maliheh Safari United States 6 175 0.7× 86 0.5× 152 1.2× 147 1.5× 52 1.1× 8 497
David R. Cheng United States 4 882 3.5× 177 1.0× 104 0.9× 94 0.9× 99 2.0× 6 1.0k
John A. Hammond United States 10 202 0.8× 169 1.0× 89 0.7× 227 2.3× 19 0.4× 14 479
Irene Saugar Spain 14 384 1.5× 102 0.6× 93 0.8× 42 0.4× 13 0.3× 16 632
Balwina Koopal Netherlands 6 409 1.6× 98 0.6× 53 0.4× 27 0.3× 22 0.4× 7 482
Lucía M. Malone New Zealand 7 254 1.0× 61 0.3× 67 0.5× 46 0.5× 49 1.0× 11 345
Jon McGinn United States 7 502 2.0× 105 0.6× 173 1.4× 83 0.8× 33 0.7× 8 556

Countries citing papers authored by Lionel Galibert

Since Specialization
Citations

This map shows the geographic impact of Lionel Galibert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lionel Galibert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lionel Galibert more than expected).

Fields of papers citing papers by Lionel Galibert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lionel Galibert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lionel Galibert. The network helps show where Lionel Galibert may publish in the future.

Co-authorship network of co-authors of Lionel Galibert

This figure shows the co-authorship network connecting the top 25 collaborators of Lionel Galibert. A scholar is included among the top collaborators of Lionel Galibert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lionel Galibert. Lionel Galibert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ali, Amr El‐Hag, Kangwen Deng, Lili Huang, et al.. (2024). Insight Into the Degradation Pathways of an AAV9. Journal of Pharmaceutical Sciences. 113(9). 2967–2973. 4 indexed citations
2.
Galibert, Lionel, Hanna Leinonen, Igor Oruetxebarria, et al.. (2022). Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy. Frontiers in Medicine. 9. 1052318–1052318. 10 indexed citations
3.
Galibert, Lionel, et al.. (2021). Monobac System–A Single Baculovirus for the Production of rAAV. Microorganisms. 9(9). 1799–1799. 13 indexed citations
4.
Galibert, Lionel, et al.. (2021). Functional roles of the membrane-associated AAV protein MAAP. Scientific Reports. 11(1). 21698–21698. 39 indexed citations
5.
Galibert, Lionel, et al.. (2018). Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system. PLoS ONE. 13(11). e0207414–e0207414. 20 indexed citations
6.
Kaikkonen, Minna U., et al.. (2018). Genetics instability of wtAAV2 genome and AAV promoter activities in the Baculovirus/Sf9 cells system. PLoS ONE. 13(7). e0199866–e0199866. 4 indexed citations
7.
Merten, Otto‐Wilhelm, et al.. (2017). Impact of Inverted Terminal Repeat Integrity on rAAV8 Production Using the Baculovirus/Sf9 Cells System. Human Gene Therapy Methods. 28(5). 277–289. 20 indexed citations
8.
Galibert, Lionel, et al.. (2015). 557. Impact of the Integrity of the ITRs on the Production of rAAV Vectors. Molecular Therapy. 23. S223–S223. 1 indexed citations
9.
Marek, Martin, Christophe Romier, Lionel Galibert, Otto-Wilhelm Merten, & Monique M. van Oers. (2013). Baculovirus VP1054 Is an Acquired Cellular PURα, a Nucleic Acid-Binding Protein Specific for GGN Repeats. Journal of Virology. 87(15). 8465–8480. 16 indexed citations
10.
Marek, Martin, Otto-Wilhelm Merten, Lionel Galibert, Just M. Vlak, & Monique M. van Oers. (2011). Baculovirus VP80 Protein and the F-Actin Cytoskeleton Interact and Connect the Viral Replication Factory with the Nuclear Periphery. Journal of Virology. 85(11). 5350–5362. 53 indexed citations
11.
Galibert, Lionel & Otto‐Wilhelm Merten. (2011). Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases. Journal of Invertebrate Pathology. 107. S80–S93. 44 indexed citations
12.
Barat‐Houari, Mouna, Frédérique Hilliou, Luc Sofer, et al.. (2006). Gene expression profiling of Spodoptera frugiperda hemocytes and fat body using cDNA microarray reveals polydnavirus-associated variations in lepidopteran host genes transcript levels. BMC Genomics. 7(1). 160–160. 56 indexed citations
13.
Galibert, Lionel, et al.. (2006). Members of the Hyposoter didymator Ichnovirus repeat element gene family are differentially expressed in Spodoptera frugiperda. Virology Journal. 3(1). 48–48. 11 indexed citations
14.
Froissart, Rémy, Denis Roze, Marilyne Uzest, et al.. (2005). Recombination Every Day: Abundant Recombination in a Virus during a Single Multi-Cellular Host Infection. PLoS Biology. 3(3). e89–e89. 102 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changyong Liang Breakdown of academic impact, for papers by Robert Heler Breakdown of academic impact, for papers by Chantal K. Guegler Breakdown of academic impact, for papers by Maliheh Safari Breakdown of academic impact, for papers by David R. Cheng Breakdown of academic impact, for papers by John A. Hammond Breakdown of academic impact, for papers by Irene Saugar Breakdown of academic impact, for papers by Balwina Koopal Breakdown of academic impact, for papers by Lucía M. Malone Breakdown of academic impact, for papers by Jon McGinn
Rankless by CCL
2026